Drw Securities, LLC Otonomy, Inc. Transaction History

Drw Securities, LLC

  • $2.32 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$2.6 - $3.95 $65,000 - $98,750
-25,000 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$3.7 - $4.75 $37,000 - $47,500
10,000 Added 66.67%
25,000 $96,000
Q4 2017

Feb 14, 2018
BUY
$2.8 - $5.55 $42,000 - $83,250
15,000
15,000 $83,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email